Private Equity

Critical guidance on your journey

In the increasingly competitive environment of private equity, great deals are harder to find and the exceptional risk becomes the rule. With deep expertise across many industries and 850+ professionals providing M&A, growth equity and ECM, debt advisory and corporate finance services globally, we deliver a deal flow consisting of the very best opportunities on the market — and help you gain the upper hand.

Contact advisor

Worldwide

1,494

deals closed in Private Equity

Worldwide

Explore all our industry-related deals

Go to deals

Biopharma Group has sold Crowthorne Group to Normec Group

Private Equity | Business Support Services

Biopharma Group has sold Crowthorne Group to Normec Group

Biopharma Group has sold Crowthorne Group Limited to Normec Group.

Learn more

Nexus has been acquired by VPS Group

Business Support Services | Other Industries | Private Equity

Nexus has been acquired by VPS Group

The private shareholders of Nexus National Security Network (Nexus) have sold the company to VPS Group.

Learn more

Livia’s Health Foods has been acquired by S-Ventures PLC

Private Equity | Consumer & Retail | Food & Beverage

Livia’s Health Foods has been acquired by S-Ventures PLC

Livia’s Health Foods (Livia’s) has been acquired by S-Ventures PLC.

Learn more

“We are very excited to announce this transaction, which we believe is a great outcome for all parties. The team at Oaklins S&W went above and beyond throughout the process. They were knowledgeable about the sector, including the buyer landscape, and provided sound guidance, support and advice throughout. This led to a highly efficient, streamlined process and we would most definitely recommend Oaklins to anyone.”

Andrew Cowen

Chairman, Biopharma Group

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=XSW&includes=featured_images,tags&language=en&limit=1&tags=private-equity

From strategy to execution: Q1 insights from the mid-market

QUARTERLY M&A ACTIVITY: In Q1 2025, Oaklins facilitated 59 transactions across a variety of sectors, driving growth amid economic complexities, with TMT leading in deal count.

Learn more